S. 4109 — Stem Cell Therapeutic and Research Reauthorization Act of 2026

This section reauthorizes the C.W. Bill Young Cell Transplantation Program by extending the authorization of appropriations through FY2031 (from FY2026), maintaining $31,009,000 annually for FY2022 through FY2026, and authorizing $33,009,000 annually for FY2027 through FY2031. (The program supports a national bone marrow donor registry and cord blood inventory to facilitate matching donors with patients needing hematopoietic stem cell transplants.)